Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk
Sairam Behera(Baylor College of Medicine), Fritz J. Sedlazeck(Baylor College of Medicine), Michael A. Eberle(Illumina (United States)), Parag H. Joshi(Southwestern Medical Center), E. Newman(Illumina (United States)), Ginger Metcalf(Baylor College of Medicine), Donna M. Muzny(Baylor College of Medicine), Medhat Mahmoud(Baylor College of Medicine), Christy L. Avery(University of North Carolina at Chapel Hill), Eric Boerwinkle(Training Programs in Epidemiology and Public Health Interventions Network), Christie M. Ballantyne(Baylor College of Medicine), Carlos J. Rodríguez(Albert Einstein College of Medicine), Robert C. Kaplan(Albert Einstein College of Medicine), Vitor Onuchic(Illumina (United States)), Richard A. Gibbs(Baylor College of Medicine), Bing Yu(The University of Texas Health Science Center at Houston), Xiao Chen(Pacific Biosciences (United States)), Santica M. Marcovina(Medpace (United States)), Vipin K. Menon(Baylor College of Medicine), Massimiliano Rossi(Illumina (United States)), Jonathan R. Belyeu(Pacific Biosciences (United States)), Ngoc Quynh Nguyen(The University of Texas Health Science Center at Houston), Qi Qi(Albert Einstein College of Medicine), Luis F. Paulin(Baylor College of Medicine), Eric Roller(Illumina (United States)), James Han(Illumina (United States))
Cited by 14
Related Papers
A global reference for human genetic variation
|Nature|2015|19.9k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k